Overview

COMMITTED TO THE DESIGN, DEVELOPMENT, AND DELIVERY OF INNOVATIVE AND CREATIVE EVIDENCE-BASED EDUCATION PROGRAMS


A Patient With Severe Asthma in Need of Additional Control

Severe asthma is thought to affect about 5% to 10% of the total population of patients with asthma. The detrimental consequences of uncontrolled severe asthma are significant, leading to serious exacerbations, deterioration of lung function, and pronounced impact on quality of life. The emergence of biologic therapies has revolutionized the treatment of severe asthma. Dr. Flavia Hoyte consults ...
Integritas Communications

Advances in Managing Fistulizing Crohn’s Disease: A Multidisciplinary Approach

The presence of fistulizing Crohn’s disease (FCD) reflects a distinct, aggressive phenotype of CD and indicates a challenging and complicated disease course necessitating an early, intense, and multidisciplinary approach to treatment. Compared with patients without perianal involvement, patients with perianal FCD have higher rates of hospitalization, surgery, and use of immunosuppressive medic...
Integritas Communications

Anemia in Chronic Kidney Disease: New Avenues to Improve Patient Outcomes

This series of four 15-minute CME Snapshot™ activities on anemia associated with CKD will provide clinicians with the latest information and research on the burden of disease in patients (including health-related quality of life and health care resource utilization); pathophysiology; the interplay of cardiovascular disease, renal disease, and patient-reported outcomes; and clinical management ...
Integritas Communications

Answering the Call in Severe Asthma Expanding Roles for Biologic Treatment Regimens

This enduring Call-a-Colleague™ educational program will guide attendees through the long-term management of severe asthma. Expert faculty will provide actionable recommendations on evaluation strategies that consider underlying mechanism of disease, data on newer biologic treatment options, and most importantly, the use of these therapies in current day practice. Interspersed throughout the p...
Integritas Communications

Are You Up to Date on Your Flu Season Response? Flexing Your Clinical Management Muscles

Influenza is a highly contagious seasonal viral infection that affects all age cohorts. While vaccination is still the best way to prevent influenza-associated illness, under-vaccination and other factors contribute to significant morbidity and mortality during influenza season. Timely use of influenza antiviral therapies can play a critical role in reducing disease severity, duration, and trans...
Integritas Communications

Assessment of Asthma Control

Although asthma treatments are widely available, between one-third and one-half of patients continue to have symptoms that regularly interfere with everyday life. These asthma-related symptoms and exacerbations result in almost 2 million emergency department visits each year, which often lead to inpatient hospital stays. Thus, there is a clear need for ongoing education about asthma management, ...
Integritas Communications

AxSpA Boot Camp: Are You Up to Date on Recent Advances?

With a multitude of possible clinical presentations and a lack of validated diagnostic criteria, late or missed diagnosis of AxSpA is all too common in clinical practice. Further complicating diagnosis, a subset of patients with AxSpA do not exhibit radiographic changes on plain film x-ray. With recent advances in the therapeutic armamentarium able to halt the irreversible structural changes ass...
Integritas Communications

Cardiovascular Considerations in COPD Management

With cardiovascular disease coexisting in up to 60% of COPD cases, optimal management of each disease is imperative to successful patient outcomes. In this Phone-a-Friend episode, Dr. MeiLan Han consults with Dr. Ty Gluckman to discuss a patient with a 5-year history of COPD and cardiovascular risk factors that may be contributing to his persistent symptoms.
Integritas Communications

Diagnosis and Management of Patients With Predominant Skin Symptoms

The educational design of this activity addresses the needs of allergy/clinical immunology, gastroenterology, dermatology, and hematology clinicians who manage patients with nonadvanced systemic mastocytosis. Nonadvanced systemic mastocytosis (SM) is a group of rare disorders characterized by mast cell accumulation that results in a significant and varied symptomatic burden to the patient. T...
Integritas Communications

Flexing Your Muscles in Familial Hypercholesterolemia Best Practices for Screening, Diagnosis, and Management

Familial hypercholesterolemia (FH) is a genetic disorder marked by high levels of circulating low-density lipoprotein cholesterol (LDL-C), leading to increased risk of premature atherosclerotic cardiovascular disease (ASCVD). Individuals with FH frequently remain undiagnosed, resulting in poor outcomes and failure to diagnose family members. Even once diagnosed, the preferred treatment options c...
Integritas Communications

Hot Topics in Blood-based Cancer Screening: Key Information on Multi-Cancer Early Detection from 2023 Spring Oncology Meetings

Early detection of cancer is essential to reducing the significant burdens associated with it. When cancer is detected at earlier stages, treatments can be initiated sooner, resulting in improved outcomes, reduced morbidity and mortality, and better quality of life. While the implementation of current screening guidelines has resulted in an overall reduction in cancer deaths, only 25% of cancers...
Integritas Communications

Hot Topics in Lupus: Individualizing Steroid-Sparing Regimens

Despite the known short- and long-term adverse outcomes related to glucocorticoid use, patients with SLE are still taking moderate to high daily doses of steroids. Fortunately, 2 biologic therapies aimed at different therapeutic targets in the type I interferon pathway and with better safety profiles than glucocorticoids are currently available for use. These biologics, along with off-label imm...
Integritas Communications

Hot Topics in Lupus: SLE Pathophysiology

Despite the known short- and long-term adverse outcomes related to glucocorticoid use, patients with SLE are still taking moderate to high daily doses of steroids. Fortunately, 2 biologic therapies aimed at different therapeutic targets in the type I interferon pathway and with better safety profiles than glucocorticoids are currently available for use. These biologics, along with off-label imm...
Integritas Communications

Hot Topics in Lupus: Targeted Biologic Treatment Options

Despite the known short- and long-term adverse outcomes related to glucocorticoid use, patients with SLE are still taking moderate to high daily doses of steroids. Fortunately, 2 biologic therapies aimed at different therapeutic targets in the type I interferon pathway and with better safety profiles than glucocorticoids are currently available for use. These biologics, along with off-label imm...
Integritas Communications

Making the Call in Nonadvanced Systemic Mastocytosis Optimizing Multidisciplinary Management

Series Overview Nonadvanced systemic mastocytosis (SM) is a group of rare disorders characterized by mast cell accumulation that results in a significant and varied symptomatic burden to the patient. The most prevalent of these symptoms include gastrointestinal symptoms, dermatological symptoms, and recurrent anaphylaxis in response to a variety of triggers such as food, insect venom, and medic...
Integritas Communications

Making the Rounds on Systemic Mastocytosis: Accelerating Diagnosis and Treatment

For this Interactive Showcase™ in nonadvanced systemic mastocytosis (SM), the first activity, designed as an expert-guided poster tour, will briefly review the pathophysiological drivers of SM and their implications. Subsequently, you will watch an expert roundtable video where faculty will discuss management approaches, including recent clinical trial data on emerging targeted therapies and r...
Integritas Communications

Managing the Patient With Severe Asthma and Common Comorbidities

Comorbid disease is common amongst patients with asthma and may lead to worsening asthma symptoms if not properly identified and managed. Furthermore, some patients may not respond to their first biologic treatment option, confounding management and selection of next line therapy. Dr. Njira Lugogo consults with Dr. Flavia Hoyte to discuss a treatment plan for her patient with severe, allergic as...
Integritas Communications

Overview of the 2023 GOLD Guidelines for COPD

Target Audience The educational design of this activity addresses the needs of primary care providers (PCPs), including physicians, nurse practitioners, and physician assistants who manage patients with chronic obstructive pulmonary disease (COPD). Program Overview During the first activity of the series, expert faculty will present and discuss key updates to the Global Initiative for Chron...
Integritas Communications

PrEParing to End the Epidemic: Optimizing HIV Prevention in Primary Care

This educational program will focus on how to identify and engage with patients at high risk for HIV infection, use nonjudgmental communication skills to remove the stigma associated with HIV, and foster meaningful discussions about sexual health and behavior. It will also provide practical clinical information on implementing PrEP services in primary care practice, including the safety and effi...
Integritas Communications

Reducing Risks in Asthma: Mucus Plugs and Airway Obstruction

Target Audience The educational design of this activity addresses the needs of pulmonology and clinical immunology clinicians who manage patients with severe asthma who are at risk for mucus plugs. Program Overview This Point-of-Care 201 program has been designed to educate and promote critical thinking through a discussion-based format that is accompanied by 3-dimensional animation. Expert...
Integritas Communications

Rescue Therapies for Asthma

Although asthma treatments are widely available, between one-third and one-half of patients continue to have symptoms that regularly interfere with everyday life. These asthma-related symptoms and exacerbations result in almost 2 million emergency department visits each year, which often lead to inpatient hospital stays. Thus, there is a clear need for ongoing education about asthma management, ...
Integritas Communications

Strengthening Your COVID-19 Management Technique Exercising Best Practices for Patients Hospitalized With COVID-19

Severe COVID-19 continues to plague patients at high risk, such as those with certain comorbid conditions or those who are immunocompromised. Clinicians struggle to remain up to date on evolving guidelines, treatment options, circulating subvariants, and strategies to address long COVID. In this circuit training activity " consisting of text, graphics, videos, and interactive components - D...
Integritas Communications

The HIV Journey Staying the Course Through Critical Junctions in Care

HIV is a life-long condition that is becoming increasingly complex. Clinicians must be prepared to face myriad situations over a patient’s lifespan, relating both to their HIV and to either other comorbidities or issues such as stigma or social determinants of health. In this interactive activity, you will follow a patient diagnosed as an adolescent through his lifespan with HIV to make decisi...
Integritas Communications

The PrEP Journey Charting the Course Through HIV Prevention

HIV prevention with preexposure prophylaxis (PrEP) is an essential tool for clinicians to help end the HIV epidemic. In this case-based interactive activity, you will learn the basics of assessing HIV risk, conversing with patients about sexual health, and providing PrEP, from initiation to monitoring and follow-up. Then, more challenging cases will illustrate the nuances of providing PrEP based...
Integritas Communications

Top 10 COVID-19 Special Population Queries

Even though the COVID-19 pandemic is slowly becoming endemic, there are still certain populations at higher risk of progressing to severe COVID-19 should they become infected with SARS-CoV-2. These include immunocompromised groups, older patients, patients with HIV, disabilities, challenges in social determinants of health, and racial or ethnic minorities. There are treatment considerations for ...
Integritas Communications

What’s New in the Management of COVID-19 Incorporating New Data and Updated Guidelines Into Daily Practice

Clinicians struggle to remain up to date with the rapidly changing face of COVID-19 because of novel variants and subvariants, changes to Emergency Use Authorizations, and persisting disparities in access to care. This activity will present data on and discuss the current status of the pandemic, the need for timely testing, updates to National Institutes of Health guidelines on patient identific...
Integritas Communications

What’s Next: Exploring New Treatment Avenues in Nonadvanced Systemic Mastocytosis

Systemic mastocytosis (SM) is a group of rare disorders characterized by accumulation of mast cells in internal tissues and organs, such as the liver, spleen, bone marrow, and small intestines. Patients with SM experience symptoms that include anaphylaxis, flushing, gastrointestinal issues, fatigue, and skin lesions; the lack of specific symptoms often makes diagnosis challenging. Clinicians nee...
Integritas Communications

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map